Covered recipient · General Payments record
PRIYA PATEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$408.89
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.63 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $103.36 | 5 |
| Acerta Pharma LLC | $43.96 | 3 |
| PFIZER INC. | $43.35 | 2 |
| Exact Sciences Corporation | $34.41 | 2 |
| Novo Nordisk AS | $31.22 | 2 |
| Lilly USA, LLC | $28.65 | 1 |
| DEXCOM, INC. | $26.10 | 1 |
| Astellas Pharma US Inc | $23.37 | 1 |
| GlaxoSmithKline, LLC. | $15.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.59 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105199316 | CMS |
| ABBVIE INC. | $30.17 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105199318 | CMS |
| ABBVIE INC. | $19.07 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105199320 | CMS |
| ABBVIE INC. | $13.74 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105199322 | CMS |
| ABBVIE INC. | $17.79 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105199324 | CMS |
| Astellas Pharma US Inc | $23.37 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139282770 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.76 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105556186 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.77 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104401371 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.43 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105722464 | CMS |
| Dexcom, Inc. | $26.10 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153328613 | CMS |
| Exact Sciences Corporation | $14.49 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114826699 | CMS |
| Exact Sciences Corporation | $19.92 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114826704 | CMS |
| GlaxoSmithKline, LLC. | $15.21 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116657581 | CMS |
| Lilly USA, LLC | $28.65 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135321530 | CMS |
| Novo Nordisk Inc | $13.86 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096709284 | CMS |
| Novo Nordisk Inc | $17.36 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096832816 | CMS |
| PFIZER INC. | $26.09 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131826529 | CMS |
| PFIZER INC. | $17.26 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115033 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.